Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
45.62
-0.02 (-0.03%)
Jan 27, 2026, 2:59 PM EST - Market open
Corcept Therapeutics Employees
Corcept Therapeutics had 500 employees as of December 31, 2024. The number of employees increased by 148 or 42.05% compared to the previous year.
Employees
500
Change (1Y)
148
Growth (1Y)
42.05%
Revenue / Employee
$1,482,344
Profits / Employee
$209,312
Market Cap
4.80B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 500 | 148 | 42.05% | 500 | 0 |
| Dec 31, 2023 | 352 | 53 | 17.73% | 352 | 0 |
| Dec 31, 2022 | 299 | 61 | 25.63% | 299 | 0 |
| Dec 31, 2021 | 238 | 2 | 0.85% | 238 | 0 |
| Dec 31, 2020 | 236 | 30 | 14.56% | 236 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ACADIA Pharmaceuticals | 654 |
| Amicus Therapeutics | 499 |
| Crinetics Pharmaceuticals | 437 |
| CRISPR Therapeutics AG | 393 |
| TG Therapeutics | 374 |
| Mirum Pharmaceuticals | 355 |
| Apogee Therapeutics | 196 |
| Scholar Rock Holding | 128 |
CORT News
- 5 days ago - Corcept Therapeutics Experimental Lead Drug Cuts Death Risk By 35% In Advanced Ovarian Cancer Patients, Stock Jumps - Benzinga
- 5 days ago - Corcept's cancer drug meets main goal in late-stage trial - Reuters
- 5 days ago - Overall Survival Primary Endpoint Met in Corcept's Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer - Business Wire
- 12 days ago - These under-the-radar stocks combine fast growth with big upside potential - Market Watch
- 12 days ago - CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm - PRNewsWire
- 12 days ago - Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – CORT - Business Wire
- 13 days ago - Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman - PRNewsWire
- 14 days ago - CORT INVESTIGATION: Corcept Therapeutics Investors Should Contact Block & Leviton LLP To Potentially Recover Losses - Newsfile Corp